Shandong Xinhua Pharmaceutical Company Limited revenue reports
Shandong Xinhua Pharmaceutical Company Limited financial reports, Shandong Xinhua Pharmaceutical Company Limited annual revenue in 2024. When does Shandong Xinhua Pharmaceutical Company Limited report revenue?
Shandong Xinhua Pharmaceutical Company Limited total revenue, net income and dynamics of changes in Hong Kong dollar today
Shandong Xinhua Pharmaceutical Company Limited current income and income for the latest reporting periods. Shandong Xinhua Pharmaceutical Company Limited net income is now 100 276 327 $. These are the main financial indicators of Shandong Xinhua Pharmaceutical Company Limited. The financial schedule of Shandong Xinhua Pharmaceutical Company Limited consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The financial report on the chart of Shandong Xinhua Pharmaceutical Company Limited allows you to clearly see the dynamics of fixed assets. Shandong Xinhua Pharmaceutical Company Limited total revenue on the graph is shown in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
1 910 240 998.06 $
+9.29 % ↑
108 336 517.68 $
+32.91 % ↑
31/12/2020
1 476 955 125.01 $
+13.14 % ↑
85 126 774.71 $
+28.1 % ↑
30/09/2020
1 461 476 889.92 $
+4.12 % ↑
79 682 679.34 $
-19.0642 % ↓
30/06/2020
1 706 772 982.53 $
+6.59 % ↑
92 940 013.33 $
+19.43 % ↑
31/12/2019
1 305 415 649.21 $
-
66 451 992.91 $
-
30/09/2019
1 403 688 955.24 $
-
98 451 759.92 $
-
30/06/2019
1 601 267 560.13 $
-
77 818 862.13 $
-
31/03/2019
1 747 801 359.25 $
-
81 509 086.23 $
-
Show:
to
Shandong Xinhua Pharmaceutical Company Limited financial report charts
Dates of Shandong Xinhua Pharmaceutical Company Limited finance reports: 31/03/2019, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of Shandong Xinhua Pharmaceutical Company Limited is available online for such a date - 31/03/2021. Gross profit Shandong Xinhua Pharmaceutical Company Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Shandong Xinhua Pharmaceutical Company Limited is 514 094 041 $
Shandong Xinhua Pharmaceutical Company Limited quarterly report dates
Cost of revenue Shandong Xinhua Pharmaceutical Company Limited is the total cost of producing and distributing of products and services of a company. Cost of revenue Shandong Xinhua Pharmaceutical Company Limited is 1 254 025 842 $ Total revenue Shandong Xinhua Pharmaceutical Company Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Shandong Xinhua Pharmaceutical Company Limited is 1 768 119 883 $ Operating income Shandong Xinhua Pharmaceutical Company Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Shandong Xinhua Pharmaceutical Company Limited is 133 975 056 $
Net income Shandong Xinhua Pharmaceutical Company Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Shandong Xinhua Pharmaceutical Company Limited is 100 276 327 $ Current assets Shandong Xinhua Pharmaceutical Company Limited is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Shandong Xinhua Pharmaceutical Company Limited is 2 851 444 880 $ Total assets Shandong Xinhua Pharmaceutical Company Limited refers to the total amount of assets owned by a person or entity. Total assets Shandong Xinhua Pharmaceutical Company Limited is 7 279 400 349 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
555 416 815.01 $
449 624 704.11 $
457 575 465.35 $
465 000 514.87 $
4 562 461 696.15 $
444 288 015.77 $
477 045 120.38 $
562 770 246.15 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 354 824 183.04 $
1 027 330 420.90 $
1 003 901 424.57 $
1 241 772 467.67 $
-3 257 046 046.94 $
959 400 939.47 $
1 124 222 439.75 $
1 185 031 113.10 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
1 910 240 998.06 $
1 476 955 125.01 $
1 461 476 889.92 $
1 706 772 982.53 $
1 305 415 649.21 $
1 403 688 955.24 $
1 601 267 560.13 $
1 747 801 359.25 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
1 305 415 649.21 $
1 403 688 955.24 $
1 601 267 560.13 $
1 747 801 359.25 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
144 743 943.64 $
101 545 345.36 $
139 172 299.71 $
135 335 053.20 $
72 039 947.34 $
128 639 443.72 $
98 547 482.65 $
126 166 545.11 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
108 336 517.68 $
85 126 774.71 $
79 682 679.34 $
92 940 013.33 $
66 451 992.91 $
98 451 759.92 $
77 818 862.13 $
81 509 086.23 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
83 723 785.95 $
97 661 781.90 $
54 866 827.56 $
88 880 643.98 $
-196 596 608.80 $
53 513 869.02 $
81 226 751.66 $
61 855 988.12 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
1 765 497 054.42 $
1 375 409 779.65 $
1 322 304 590.22 $
1 571 437 929.33 $
1 233 375 701.87 $
1 275 049 511.53 $
1 502 720 077.48 $
1 621 634 814.14 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
3 080 643 437.05 $
2 902 841 178.92 $
2 795 273 478.94 $
3 036 737 938.71 $
-
2 327 491 151.40 $
2 488 294 378.91 $
2 516 960 117.63 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
7 864 517 062.23 $
7 663 082 225.33 $
7 234 068 987.52 $
7 342 038 283.03 $
-
6 535 485 343.53 $
6 586 292 373.90 $
6 525 568 802.07 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
987 053 823.22 $
924 557 485.35 $
1 025 581 718.16 $
1 203 947 559.65 $
-
679 301 260.92 $
715 173 619.06 $
700 422 076.59 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
-
2 282 372 620.99 $
2 446 569 400.30 $
2 541 034 368.63 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
-
3 274 565 757.96 $
3 415 820 021.92 $
3 385 172 296.21 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
-
50.10 %
51.86 %
51.88 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
3 629 521 972.88 $
3 482 921 706.63 $
3 360 792 084.89 $
3 266 534 524.63 $
3 125 907 390.89 $
3 125 907 390.89 $
3 039 559 050.20 $
3 015 545 566.24 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-
152 909 475.74 $
103 233 789.91 $
60 828 276.84 $
Last revenue report of Shandong Xinhua Pharmaceutical Company Limited was 31/03/2021. According to last financial report total revenue in Shandong Xinhua Pharmaceutical Company Limited was 1 910 240 998.06 Hong Kong dollar and changed by +9.29% since last year. Net income in Shandong Xinhua Pharmaceutical Company Limited was 108 336 517.68 $ in last quartal, net income changes to +32.91%.
Current cash Shandong Xinhua Pharmaceutical Company Limited - the sum of all of the cash a company has on the date of report. Current cash Shandong Xinhua Pharmaceutical Company Limited is 913 617 440 $
Shandong Xinhua Pharmaceutical Company Limited stocks data
